NZ598712A - Methods and compositions for diagnosis and prognosis of renal injury and renal failure - Google Patents

Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Info

Publication number
NZ598712A
NZ598712A NZ598712A NZ59871210A NZ598712A NZ 598712 A NZ598712 A NZ 598712A NZ 598712 A NZ598712 A NZ 598712A NZ 59871210 A NZ59871210 A NZ 59871210A NZ 598712 A NZ598712 A NZ 598712A
Authority
NZ
New Zealand
Prior art keywords
apolipoprotein
renal
prognosis
diagnosis
compositions
Prior art date
Application number
NZ598712A
Other languages
English (en)
Inventor
Joseph Anderberg
Jeff Gray
Paul Mcpherson
Kevin Nakamura
James Patrick Kampf
Original Assignee
Astute Medical Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astute Medical Inc filed Critical Astute Medical Inc
Priority to NZ624609A priority Critical patent/NZ624609A/en
Publication of NZ598712A publication Critical patent/NZ598712A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/92—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving lipids, e.g. cholesterol, lipoproteins, or their receptors
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/46—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans from vertebrates
    • G01N2333/47—Assays involving proteins of known structure or function as defined in the subgroups
    • G01N2333/4701—Details
    • G01N2333/4748—Details p53
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2333/00—Assays involving biological materials from specific organisms or of a specific nature
    • G01N2333/435—Assays involving biological materials from specific organisms or of a specific nature from animals; from humans
    • G01N2333/775—Apolipopeptides
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/34—Genitourinary disorders
    • G01N2800/347—Renal failures; Glomerular diseases; Tubulointerstitial diseases, e.g. nephritic syndrome, glomerulonephritis; Renovascular diseases, e.g. renal artery occlusion, nephropathy
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/50—Determining the risk of developing a disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/60—Complex ways of combining multiple protein biomarkers for diagnosis

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Biotechnology (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Medicinal Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Endocrinology (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
NZ598712A 2009-08-28 2010-08-27 Methods and compositions for diagnosis and prognosis of renal injury and renal failure NZ598712A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
NZ624609A NZ624609A (en) 2009-08-28 2010-08-27 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Applications Claiming Priority (15)

Application Number Priority Date Filing Date Title
US23811509P 2009-08-28 2009-08-28
US23813409P 2009-08-28 2009-08-28
US23812509P 2009-08-28 2009-08-28
US23812909P 2009-08-28 2009-08-28
US23812809P 2009-08-28 2009-08-28
US23812109P 2009-08-28 2009-08-28
US23812009P 2009-08-28 2009-08-28
US23811809P 2009-08-28 2009-08-28
US23812709P 2009-08-28 2009-08-28
US23812309P 2009-08-28 2009-08-28
US24400209P 2009-09-18 2009-09-18
US24399109P 2009-09-18 2009-09-18
US24399709P 2009-09-18 2009-09-18
US24399309P 2009-09-18 2009-09-18
PCT/US2010/046910 WO2011025917A1 (en) 2009-08-28 2010-08-27 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Publications (1)

Publication Number Publication Date
NZ598712A true NZ598712A (en) 2014-05-30

Family

ID=43628398

Family Applications (2)

Application Number Title Priority Date Filing Date
NZ598712A NZ598712A (en) 2009-08-28 2010-08-27 Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ624609A NZ624609A (en) 2009-08-28 2010-08-27 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Family Applications After (1)

Application Number Title Priority Date Filing Date
NZ624609A NZ624609A (en) 2009-08-28 2010-08-27 Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Country Status (9)

Country Link
US (2) US20120315649A1 (enExample)
EP (3) EP2470905B1 (enExample)
JP (2) JP5775874B2 (enExample)
CN (2) CN102792161B (enExample)
AU (1) AU2010286559B2 (enExample)
CA (1) CA2772336A1 (enExample)
HK (1) HK1208074A1 (enExample)
NZ (2) NZ598712A (enExample)
WO (1) WO2011025917A1 (enExample)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP5763098B2 (ja) 2009-12-20 2015-08-12 アスチュート メディカル，インコーポレイテッド 腎損傷および腎不全の診断および予後診断のための方法ならびに組成物
DK2666872T3 (en) * 2010-02-05 2016-07-25 Astute Medical Inc Methods and compositions for the diagnosis and prognosis of renal injury and renal insufficiency
US20130203074A1 (en) 2010-06-23 2013-08-08 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN103080743B (zh) * 2010-06-23 2015-07-22 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断及预后的方法和组合物
US10557856B2 (en) 2010-09-24 2020-02-11 University Of Pittsburgh-Of The Commonwealth System Of Higher Education Biomarkers of renal injury
US9551720B2 (en) 2011-01-26 2017-01-24 University of Pittsburgh—Of the Commonwaelth System of Higher Education Urine biomarkers for prediction of recovery after acute kidney injury: proteomics
EP2503340A1 (en) * 2011-03-22 2012-09-26 Fundació Institut de Recerca Hospital Universitari Vall d'Hebron, Fundació Privada Diagnostic marker for relapsing primary idiopathic focal segmental glomerulosclerosis
TW201250248A (en) * 2011-04-25 2012-12-16 Kyowa Medex Co Ltd Prognostication method of renal failure
WO2012155123A2 (en) * 2011-05-12 2012-11-15 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2013086359A1 (en) 2011-12-08 2013-06-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
US20150293131A1 (en) * 2012-04-02 2015-10-15 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of sepsis
CA3158996C (en) * 2013-01-17 2024-06-04 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN104569417B (zh) * 2013-10-12 2016-06-01 广州瑞博奥生物科技有限公司 一种用于早期诊断急性肾损伤的抗体芯片试剂盒
CN105917229B (zh) 2013-12-03 2019-04-26 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
WO2016164854A1 (en) 2015-04-09 2016-10-13 Astute Medical, Inc. Methods and compositions for diagnosis and prognosis of renal injury and renal failure
CN107735147A (zh) * 2015-05-12 2018-02-23 阿斯图特医药公司 用于肾损伤和肾衰竭的诊断和预后的方法和组合物
AU2017277305A1 (en) 2016-06-06 2018-12-20 Astute Medical, Inc. Management of acute kidney injury using insulin-like growth factor-binding protein 7 and tissue inhibitor of metalloproteinase 2
CN112384807A (zh) 2018-05-24 2021-02-19 雷尼布斯治疗公司 治疗有风险患有肾损伤和肾衰竭的患者的方法
CN117825674A (zh) * 2023-12-28 2024-04-05 南方医科大学南方医院 用于评估肝病预后的分子标志物及诊断试剂盒

Family Cites Families (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5223409A (en) 1988-09-02 1993-06-29 Protein Engineering Corp. Directed evolution of novel binding proteins
US5939272A (en) 1989-01-10 1999-08-17 Biosite Diagnostics Incorporated Non-competitive threshold ligand-receptor assays
US5028535A (en) 1989-01-10 1991-07-02 Biosite Diagnostics, Inc. Threshold ligand-receptor assay
US5922615A (en) 1990-03-12 1999-07-13 Biosite Diagnostics Incorporated Assay devices comprising a porous capture membrane in fluid-withdrawing contact with a nonabsorbent capillary network
WO1992005282A1 (en) 1990-09-14 1992-04-02 Biosite Diagnostics, Inc. Antibodies to complexes of ligand receptors and ligands and their utility in ligand-receptor assays
US5955377A (en) 1991-02-11 1999-09-21 Biostar, Inc. Methods and kits for the amplification of thin film based assays
ATE177841T1 (de) 1991-04-10 1999-04-15 Biosite Diagnostics Inc ''crosstalk''- oder übersprech-inhibitoren und ihre verwendung
EP0579767B1 (en) 1991-04-11 2000-08-23 Biosite Diagnostics Inc. Novel conjugates and assays for simultaneous detection of multiple ligands
US6143576A (en) 1992-05-21 2000-11-07 Biosite Diagnostics, Inc. Non-porous diagnostic devices for the controlled movement of reagents
US5885527A (en) 1992-05-21 1999-03-23 Biosite Diagnostics, Inc. Diagnostic devices and apparatus for the controlled movement of reagents without membrances
US5494829A (en) 1992-07-31 1996-02-27 Biostar, Inc. Devices and methods for detection of an analyte based upon light interference
US5824799A (en) 1993-09-24 1998-10-20 Biosite Diagnostics Incorporated Hybrid phthalocyanine derivatives and their uses
US6113855A (en) 1996-11-15 2000-09-05 Biosite Diagnostics, Inc. Devices comprising multiple capillarity inducing surfaces
US5947124A (en) 1997-03-11 1999-09-07 Biosite Diagnostics Incorporated Diagnostic for determining the time of a heart attack
US6057098A (en) 1997-04-04 2000-05-02 Biosite Diagnostics, Inc. Polyvalent display libraries
AU1674400A (en) * 1998-12-21 2000-07-12 Monash University Kidney disease detection and treatment
WO2002048329A2 (en) * 2000-11-20 2002-06-20 Idun Pharmaceuticals, Inc. Membrane derived caspase-3, compositions comprising the same and methods of use therefor
WO2002081515A1 (fr) * 2001-04-03 2002-10-17 Kyowa Hakko Kogyo Co., Ltd. Proteine de liaison de facteur de croissance de type insuline
US20030003588A1 (en) * 2001-06-28 2003-01-02 Comper Wayne D. Method for kidney disease detection by protein profiling
EP2360475B1 (en) * 2003-03-27 2019-10-02 Children's Hospital Medical Center A method and kit for detecting the early onset of renal tubular cell injury
CN1791797A (zh) * 2003-03-27 2006-06-21 儿童医院医疗中心 用于检测肾小管细胞损伤的早发的方法和试剂盒
US7416854B2 (en) * 2004-01-22 2008-08-26 Promega Corporation Luminogenic and nonluminogenic multiplex assay
US20090215046A1 (en) * 2004-01-27 2009-08-27 Compugen Ltd. Novel nucleotide and amino acid sequences, and assays methods of use thereof for diagnosis of colon cancer
US20050272101A1 (en) * 2004-06-07 2005-12-08 Prasad Devarajan Method for the early detection of renal injury
JP4991547B2 (ja) * 2004-09-28 2012-08-01 クアーク・ファーマスーティカルス、インコーポレイテッド 脱毛症、急性腎不全および他の疾患の治療のためのオリゴリボヌクレオチドおよびその使用の方法
US7141382B1 (en) * 2004-10-12 2006-11-28 Parikh Chirag R Methods for detection of IL-18 as an early marker for diagnosis of acute renal failure and predictor of mortality
CN101163971B (zh) * 2004-12-20 2013-03-20 免疫体公司 测定作为肾病诊断标记物的嗜中性粒细胞明胶酶相关性脂笼蛋白
WO2006102979A2 (de) * 2005-03-31 2006-10-05 Johannes Gutenberg-Universität Mainz Entzündungsmarker und kombinationen davon als biochemische marker bei kardiovaskulären erkrankungen
EP1880332A4 (en) * 2005-04-27 2010-02-17 Emiliem NOVEL METHODS AND DEVICES FOR EVALUATING TOXIC SUBSTANCES
TW200716764A (en) * 2005-05-02 2007-05-01 Genenews Inc Bladder cancer biomarkers and uses thereof
WO2006133399A1 (en) * 2005-06-08 2006-12-14 Hitachi Chemical Research Center, Inc. METHOD FOR PREDICTING IMMUNE RESPONSE TO NEOPLASTIC DISEASE BASED ON mRNA EXPRESSION PROFILE IN NEOPLASTIC CELLS AND STIMULATED LEUKOCYTES
US7662578B2 (en) * 2006-04-21 2010-02-16 Children's Hospital Medical Center Method and kit for the early detection of impaired renal status
US8129135B2 (en) * 2006-04-24 2012-03-06 Medizinische Universität Wien Method for diagnosing cardiovascular diseases
PL2115477T3 (pl) * 2007-01-25 2015-12-31 Hoffmann La Roche Zastosowanie IGFBP-7 do oceny niewydolności serca
EP2134866A2 (en) * 2007-04-10 2009-12-23 Integragen Human diabetes susceptibility tnfrsf10b gene
US20110183434A1 (en) * 2008-01-17 2011-07-28 Myles Wolf Diagnostic methods and kits using fibroblast growth factor-23
CN104020284B (zh) * 2008-10-21 2016-08-24 阿斯图特医药公司 用于诊断和预后肾损伤和肾衰竭的方法和组合物

Also Published As

Publication number Publication date
JP2013503344A (ja) 2013-01-31
US20120315649A1 (en) 2012-12-13
JP5775874B2 (ja) 2015-09-09
NZ624609A (en) 2015-12-24
JP2015212704A (ja) 2015-11-26
CN102792161A (zh) 2012-11-21
AU2010286559B2 (en) 2015-01-22
CN102792161B (zh) 2014-11-12
CA2772336A1 (en) 2011-03-03
EP2894473B1 (en) 2016-09-21
HK1208074A1 (en) 2016-02-19
HK1172691A1 (en) 2013-04-26
EP2894473A1 (en) 2015-07-15
JP6054481B2 (ja) 2016-12-27
US20150204892A1 (en) 2015-07-23
EP2470905B1 (en) 2015-01-07
WO2011025917A1 (en) 2011-03-03
AU2010286559A1 (en) 2012-04-05
EP2470905A4 (en) 2013-08-14
CN104483488A (zh) 2015-04-01
EP2470905A1 (en) 2012-07-04
EP3151005A1 (en) 2017-04-05

Similar Documents

Publication Publication Date Title
NZ598712A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ705411A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ594771A (en) Methods and compositions for diagnosis and prognosis of renal injury and failure
NZ628843A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ600160A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ606124A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ700695A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ610356A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ625423A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ592365A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ605698A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ608384A (en) Biomarkers of renal injury
NZ604873A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ608316A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
NZ628085A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure
WO2010096154A3 (en) Compositions and methods for diagnosis and prognosis of colorectal cancer
NZ615010A (en) Detection of sleep onset
WO2013113012A3 (en) Methods for profiling and quantitating cell-free rna
NZ598741A (en) Methods and composition for diagnosis and prognosis of renal injury and renal failure by performing assays to detect metalloproteinase inhibitor 4 on a body fluid sample
EP1989551A4 (en) METHOD OF DETECTING OR DIAGNOSING NEURODEGENERATIVE DISEASE OR DISEASE
WO2014004889A3 (en) Plasma analytes predict diagnosis and prognosis of thoracic aortic aneurysm
WO2012061068A3 (en) Method of using a tracer for monitoring water treatment agents in a wet air scrubber
MX336280B (es) Metodos y composiciones para diagnosticos y pronosticos de lesion renal y falla renal.
MX2014000283A (es) Metodos y composiciones para diagnóstico y pronóstico de lesión e insuficiencia renal.
NZ605561A (en) Methods and compositions for diagnosis and prognosis of renal injury and renal failure

Legal Events

Date Code Title Description
PSEA Patent sealed
RENW Renewal (renewal fees accepted)

Free format text: PATENT RENEWED FOR 3 YEARS UNTIL 27 AUG 2017 BY FB RICE

Effective date: 20140902

LAPS Patent lapsed